Subacute Combined Degeneration with High Serum Vitamin b12 Level and Abnormal Vitamin b12 Binding Protein: New Cause of an Old Syndrome

Archives of Neurology

Volumn 50, Issue 7, 1993, Pages 739-742

  Reynolds, E H ^a   Bottiglieri, T ^a   Laundy, M ^a   Stern, J ^a   Payan, J ^b   Linnell, J ^c   Faludy, J ^c  

^a Departments of Neurology   (United States)

^b Clinical Neurophysiology   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DISEASE COURSE; DRUG BLOOD LEVEL; HUMAN; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SPINAL CORD ATROPHY; VITAMIN BLOOD LEVEL;

ADULT; CASE REPORT; ERYTHROCYTES; HUMAN; MALE; SPINAL CORD DISEASES; TRANSCOBALAMINS; VITAMIN B 12 DEFICIENCY;

EID: 0027163152     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1993.00540070055015     Document Type: Article

References (14)

1. Reynolds EH. Folic acid, vitamin B12, and the nervous system: historical aspects. In: Botez Ml, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry and Internal Medicine. New York, NY: Raven Press; 1979:1-5.
2. Leichtenstern O. Progressive Perniciose Anamie bei Tabeskranken. Dtsch Med Wochenschr. 1884;10:849-850.
3. Russell JSR, Batten FE, Collier J. Subacute combined degeneration of the spinal cord. Brain. 1900;23:39-110.
4. Woltman HW, Heck FJ. Funicular degeneration of the spinal cord without pernicious anemia. Arch Intern Med. 1937;60:272-300.
5. Pincus JH. Folic acid deficiency: a cause of subacute combined system degeneration. In: Botez Ml, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry and Internal Medicine. New York, NY: Raven Press; 1979:427-433.
6. Lever EG, Elwes RDC, Williams A, Reynolds EH. Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment. J Neurol Neurosurg Psychiatry. 1986;49:1203-1207.
7. Victor M, Lear AA. Subacute combined degeneration of the spinal cord: current concepts of the disease process: value of serum vitamin B12 determinations in clarifying some of the common clinical problems. Am J Med. 1956;20:896-911.
8. Chanarin I. The Megaloblastic Anaemias. Oxford, England: Blackwell Scientific Publications; 1979.
9. Shorvon SD, Carney MWP, Chanarin I, Reynolds EH. The neuropsychiatry of megaloblastic anaemia. BMJ. 1980;281:1036-1038.
10. Bottiglieri T, Godfrey P, Carney MWP, Toone BK, Reynolds EH. CSF S-adenosylmethionine in neurological and psychiatric patients: effects of treatment with parenteral and oral S-adenosylmethionine. In: Linnell JC, Bhatt HR, eds. Biomedicine and Physiology of Vitamin B12. London, England: Children's Medical Charity; 1990:167-174.
11. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720-1728.
12. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency, II: relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34:99-107.
13. Schwartz SO, Kaplan SR, Armstrong BE. The long-term evaluation of folic acid in the treatment of pernicious anaemia. J Lab Clin Med. 1950;35: 984-988.
14. Hommes OR, Hollinger JL, JL, Jansen MJT, Schoofs M, vanderWiel TH, Kok JCN. Convulsant properties of folate compounds: some considerations and speculations. In: Botez MI, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry and Internal Medicine. New York, NY: Raven Press; 1979:285-316.